Login / Signup
Jiaqian Dong
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Computational Approaches
Benchmark Datasets
Key Features
Top Venues
ISAIMS
</>
Publications
</>
Jiaqian Dong
Discussions of Chemical, Biological, and Economic Features of two FDA Authorized Antivirals Against COVID-19: Molnupiravir and Paxlovid.
ISAIMS
(2022)